Similar articles

• The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.

  Gottlieb AA, Maziarz GA, Tamaki N, Sutcliffe SB. Gottlieb AA, et al. J Immunol. 1980 Feb;124(2):885-92. J Immunol. 1980. PMID: 7356716
• Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor.

  Horsmanheimo M, Krohn K, Virolainen M. Horsmanheimo M, et al. J Invest Dermatol. 1977 Jan;68(1):10-5. doi: 10.1111/1523-1747.ep12485128. J Invest Dermatol. 1977. PMID: 318672
• [Nontuberculous mycobacteriosis. Report of 2 cases of infection by mycobacteria of the MAI (atypical Mycobacteria) group and its treatment with cephalosporins].

  Marticorena BE, Micheli ZA, Armella MA, Kevorkof GV, Nigro DR. Marticorena BE, et al. Rev Fac Cien Med Univ Nac Cordoba. 1987;45(1):28, 31-2. Rev Fac Cien Med Univ Nac Cordoba. 1987. PMID: 3449918 Spanish. No abstract available.
• [Mycobacteriosis. An increasing incidence in human pathology].

  Bartsch P, Fraselle R, Koemoth P. Bartsch P, et al. Rev Med Liege. 1991 Oct;46(10):542-53. Rev Med Liege. 1991. PMID: 1957074 Review. French. No abstract available.
• A possible relationship between delayed hypersensitivity and cell-mediated immunity.

  Salvin SB, Neta R. Salvin SB, et al. Am Rev Respir Dis. 1975 Apr;111(4):373-7. doi: 10.1164/arrd.1975.111.4.373. Am Rev Respir Dis. 1975. PMID: 47728 Review. No abstract available.